Share:
Share this content in WeChat
X
• Clinlcal Guidelines & Expert Consensu •
Expert consensus on whole-process safety management for MRI examinations in patients with in-vivo implants (2026)
Radiation Interventional Nursing Committee of the Chinese Nursing Association

DOI:10.12015/issn.1674-8034.2026.11.001.


[Abstract] Magnetic resonance imaging (MRI) examination for patients with in vivo implants faces safety risks such as thermal effects, mechanical effects, and electromagnetic effects. Relevant guidelines at home and abroad have proposed inspection recommendations for some implants, but there is still a lack of systematic consensus on key clinical issues such as safety management, field strength selection, and non-compatible implant inspection conditions for different types of implants. Led by the Professional Committee of Radiation Intervention of the Chinese Nursing Association, more than 30 experts from imaging departments, evidence-based medicine and clinically related departments were organized. Based on the systematic review of the latest research evidence and relevant standard guidelines at home and abroad, combined with clinical practice, this consensus was formulated after several rounds of expert demonstration.The consensus puts forward 19 recommendations, with risk stratification assessment and multidisciplinary collaborative screening before examination, SAR parameter setting and real-time monitoring and emergency response during examination, programmed reexamination and follow-up of instruments after examination, personnel training and quality improvement of continuous management as the main line, aiming to provide operable practical guidance for medical institutions at all levels and effectively ensure the safety of patients ' MRI examinations.
[Keywords] magnetic resonance imaging;in vivo implants;implantable electronic devices;safety screening;expert consensus

Radiation Interventional Nursing Committee of the Chinese Nursing Association  

Corresponding author: ZHANG S (Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing 100044), E-mail: zhangsu3702@sina.com ZENG X H (Department of Imaging Center, The First Affiliated Hospital of Nanchang University, Nanchang 330006), E-mail: hh_8998@qq.com

Conflicts of interest   None.

Received  2026-07-08
Accepted  2026-09-22
DOI: 10.12015/issn.1674-8034.2026.11.001
DOI:10.12015/issn.1674-8034.2026.11.001.

[1]
FILICE S, PAVARANI A, PLACCI A, et al. Multidisciplinary protocol for 1.5T MRI in adult patients with active implantable medical devices: safety and efficacy in a five-year single-center experience[J]. J Magn Reson Imag, 2026, 63(5): 1392-1401. DOI: 10.1002/jmri.70188.
[2]
HARWOOD M, FAHRENHOLTZ S J, WELLNITZ C V, et al. MRI in adult patients with active and inactive implanted MR-conditional, MR-nonconditional, and other devices[J/OL]. Radiographics, 2024, 44(3): e230102 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/38421911/. DOI: 10.1148/rg.230102.
[3]
RUSSO R J, GAKENHEIMER-SMITH L, BIRGERSDOTTER-GREEN U M, et al. HRS call-to-action: Improved MRI access for patients with cardiovascular implantable electronic devices[J/OL]. Heart Rhythm, 2025, 22(9): e821-e836 [2026-07-07]. https://www.heartrhythmjournal.com/article/S1547-5271(25)02347-1/fulltext. DOI: 10.1016/j.hrthm.2025.04.028.
[4]
PATERSON D IAN, WHITE J A, BUTLER C R, et al. 2021 update on safety of magnetic resonance imaging: joint statement from Canadian cardiovascular society/Canadian society for cardiovascular magnetic resonance/Canadian heart rhythm society[J]. Can J Cardiol, 2021, 37(6): 835-847. DOI: 10.1016/j.cjca.2021.02.012.02.012.
[5]
YAO A P, MURBACH M, GOREN T, et al. Induced radiofrequency fields in patients undergoing MR examinations: insights for risk assessment[J/OL]. Phys Med Biol, 2021, 66(18): 185014 [2026-07-07]. https://iopscience.iop.org/article/10.1088/1361-6560/ac212d. DOI: 10.1088/1361-6560/ac212d.
[6]
DELFINO J G, KRAINAK D M, FLESHER S A, et al. MRI-related FDA adverse event reports: a 10-yr review[J]. Med Phys, 2019, 46(12): 5562-5571. DOI: 10.1002/mp.13768./mp.13768.
[7]
WAN E Y, ROGERS A J, LAVELLE M, et al. Periprocedural management and multidisciplinary care pathways for patients with cardiac implantable electronic devices: a scientific statement from the American heart association[J/OL]. Circulation, 2024, 150(8) [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/38984417/. DOI: 10.1161/CIR.0000000000001264.
[8]
KIM D, COLLINS J D, WHITE J A, et al. SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic device[J/OL]. J Cardiovasc Magn Reson, 2024, 26(1): 100995 [2026-07-07]. https://www.sciencedirect.com/science/article/pii/S1097664724009864via%3Dihub. DOI: 10.1016/j.jocmr.2024.100995.
[9]
STÜHLINGER M, BURRI H, VERNOOY K, et al. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices[J]. Europace, 2022, 24(9): 1512-1537. DOI: 10.1093/europace/euac040.
[10]
The Cardiac Electrophysiology and Pacemaker Branch of the Chinese Medical Association, Arrhythmia Technology Branch of the China Medical Equipment Association, Cardiology Professional Committee of the Chinese Medical Doctors Association. Recommendations on the standard procedure for magnetic resonance imaging of cardiovascular implantable electronic devices[J]. Chin J Cardiac Arrhyth, 2026, 30(2): 100-109. DOI: 10.3760/cma.j.cn113859-20251224-00199.
[11]
Nursing Group of Radiology Branch of Chinese Medical Association. Consensus on standardized nursing and operational practices for MRI contrast-enhanced examinations in patients with cardiac electronic implantable devices[J]. Radiol Pract, 2025, 40(2): 141-148. DOI: 10.13609/j.cnki.1000-0313.2025.02.002.
[12]
LIANG H D, YUAN X S, CUI X Y, et al. Application of implantable medical devices in magnetic resonance imaging examination and clinical recommendations[J]. Chin J Magn Reson Imaging, 2024, 15(4): 153-158. DOI: 10.12015/issn.1674-8034.2024.04.024.
[13]
SCHALLER R D, BRUNKER T, RILEY M P, et al. Magnetic resonance imaging in patients with cardiac implantable electronic devices with abandoned leads[J]. JAMA Cardiol, 2021, 6(5): 549-556. DOI: 10.1001/jamacardio.2020.7572.
[14]
GREENHILL M J, RANGAN P, SU W, et al. MRI in patients with cardiovascular implantable electronic devices and fractured or abandoned leads[J/OL]. Radiol Cardiothorac Imaging, 2024, 6(3): e230303 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/38869431/. DOI: 10.1148/ryct.230303.
[15]
BROUWERS M C, KHO M E, BROWMAN G P, et al. AGREE II: advancing guideline development, reporting and evaluation in health care[J]. J Clin Epidemiol, 2010, 63(12): 1308-1311. DOI: 10.1016/j.jclinepi.2010.07.001.
[16]
LU C C, LU T T, GE L, et al. Use of AMSTAR-2 in the methodological assessment of systematic reviews: protocol for a methodological study[J/OL]. Ann Transl Med, 2020, 8(10): 652 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/32566589/. DOI: 10.21037/atm-20-392a.
[17]
Oxford Centre for Evidence-Based Medicine. The Oxford 2011 Levels of Evidence[EB/OL]. [2025-03-05]. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.
[18]
RAHSEPAR A ALI, ZIMMERMAN S L, HANSFORD R, et al. The relationship between MRI radiofrequency energy and function of nonconditional implanted cardiac devices: a prospective evaluation[J]. Radiology, 2020, 295(2): 307-313. DOI: 10.1148/radiol.2020191132.
[19]
RA J, OBERDIER M T, SUZUKI M, et al. Implantable defibrillator system shock function, mortality, and cause of death after magnetic resonance imaging[J]. Ann Intern Med, 2023, 176(3): 289-297. DOI: 10.7326/M22-2653.
[20]
ASTM International. ASTM F2503-20: Standard practice for marking medical devices and other items for safety in the magnetic resonance environment[S]. West Conshohocken, PA: ASTM International, 2020.
[21]
International Organization for Standardization. ISO/TS 10974:2018: Assessment of the safety of magnetic resonance imaging for patients with an active implantable medical device[S]. Geneva: ISO, 2018.
[22]
NORDIN L E, ÅBERG K, KIHLBERG J, et al. ESR Essentials: basic physics of MR safety: practice recommendations by the European Society for Magnetic Resonance in Medicine and Biology[J]. Eur Radiol, 2025, 35(2): 572-579. DOI: 10.1007/s00330-024-10999-8.
[23]
DENEKE T, KUTYIFA V, HINDRICKS G, et al. Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European Association of Cardiovascular Imaging of the European Society of Cardiology[J/OL]. Europace, 2024, 26(5): euae108 [2026-07-07]. https://academic.oup.com/europace/article/26/5/euae108/7672946. DOI: 10.1093/europace/euae108.
[24]
TAYLOR C R, ANTTILA E D, CHARLEBOIS S J, et al. MRI safety considerations for permanent magnet implants in muscle[J]. J Magn Reson Imag, 2026, 63(2): 563-573. DOI: 10.1002/jmri.70126.
[25]
SILEMEK B, SEIFERT F, YALAZ M, et al. Read my leads: subject-specific RF hazard assessment and mitigation for DBS implants in MRI[J]. Magn Reson Med, 2026, 95(4): 2316-2330. DOI: 10.1002/mrm.70186.
[26]
BOUTET A, HANCU I, SAHA U, et al. 3-Tesla MRI of deep brain stimulation patients: safety assessment of coils and pulse sequences[J]. J Neurosurg, 2020, 132(2): 586-594. DOI: 10.3171/2018.11.jns181338.
[27]
DAVIDSON B, TAM F, YANG B, et al. Three-tesla magnetic resonance imaging of patients with deep brain stimulators: results from a phantom study and a pilot study in patients[J]. Neurosurgery, 2021, 88(2): 349-355. DOI: 10.1093/neuros/nyaa439.
[28]
JIN K X, LIU X, HU S, et al. Discussion on magnetic resonance compatibility of implantable brain-computer interface devices[J]. Chin J Med Instrum, 2024, 48(5): 486-492. DOI: 10.12455/j.issn.1671-7104.240232.
[29]
KAWALA-STERNIUK A, BROWARSKA N, AL-BAKRI A, et al. Summary of over fifty years with brain-computer interfaces: a review[J/OL]. Brain Sci, 2021, 11(1): 43 [2026-07-07]. https://www.mdpi.com/2076-3425/11/1/43. DOI: 10.3390/brainsci11010043.
[30]
ALBERALAR N D, REIS J, PIECHOTTA P L, et al. Complications of cochlear implants with MRI scans in different body regions: type, frequency and impact[J/OL]. Insights Imag, 2023, 14(1): 9 [2026-07-07]. https://link.springer.com/article/10.1186/s13244-022-01353-x. DOI: 10.1186/s13244-022-01353-x.
[31]
HELBIG S, THIEMANN N, HATTINGEN E, et al. Prospective study on magnetic resonance imaging in cochlear implant patients[J]. Eur Arch Oto Rhino Laryngol, 2024, 281(3): 1231-1242. DOI: 10.1007/s00405-023-08224-1.
[32]
DEWEY R S, BOWTELL R, KITTERICK P. A global survey of healthcare professionals undertaking MRI of patients with cochlear implants: a heterogeneity of practice and opinions[J/OL]. Br J Radiol, 2022, 95(1137): 20220213 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/35848757/. DOI: 10.1259/bjr.20220213.
[33]
Cochlear Limited. Cochlear™ Nucleus® Implants Magnetic Resonance Imaging (MRI) guidelines for Europe, Middle East, Africa[EB/OL]. (2025-10-12) [2026-09-21]. https://www.cochlear.com/warnings.
[34]
PATEL E J, WU X, MCLOUTH J, et al. Pain, safety, and image quality of magnetic resonance imaging with cochlear implants: a prospective trial[J]. Otolaryngol, 2025, 173(3): 705-712. DOI: 10.1002/ohn.1301.
[35]
PLOUX S, STRIK M, DEMONIÈRE F, et al. Remote interrogation and reprogramming of cardiac implantable electronic devices using a custom multivendor solution[J]. Heart Rhythm, 2023, 20(4): 547-551. DOI: 10.1016/j.hrthm.2022.12.015.
[36]
KIANG A, AL-DEIRI D, MING WANG T K, et al. Late-gadolinium enhancement predicts appropriate device therapies in nonischemic recipients of primary prevention implantable cardioverter-defibrillators[J]. Heart Rhythm, 2025, 22(9): 2340-2350. DOI: 10.1016/j.hrthm.2025.01.003.
[37]
MARTINEZ J A, SERANO P, ENNIS D B. Patient orientation affects lead-tip heating of cardiac active implantable medical devices during MRI[J/OL]. Radiol Cardiothorac Imaging, 2019, 1(3): e190006 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/32076667/. DOI: 10.1148/ryct.2019190006.
[38]
MEIER C, ISRAEL C, EISENBLÄTTER M, et al. Safety of magnetic resonance imaging in patients with cardiac implantable electronic devices and abandoned or epicardial leads: a systematic review and meta-analysis[J/OL]. Europace, 2024, 26(6): euae165 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/38918179/. DOI: 10.1093/europace/euae165.
[39]
VUORINEN A M, PAAKKANEN R, KARVONEN J, et al. Magnetic resonance imaging safety in patients with abandoned or functioning epicardial pacing leads[J]. Eur Radiol, 2022, 32(6): 3830-3838. DOI: 10.1007/s00330-021-08469-6.
[40]
BHUVA A N, MORALEE R, BRUNKER T, et al. Evidence to support magnetic resonance conditional labelling of all pacemaker and defibrillator leads in patients with cardiac implantable electronic devices[J]. Eur Heart J, 2022, 43(26): 2469-2478. DOI: 10.1093/eurheartj/ehab350.
[41]
STOJANOVSKA J, IBRAHIM E H. Beyond the AJR: "magnetic resonance imaging in patients with cardiac implantable electronic devices with abandoned leads"[J/OL]. Am J Roentgenol, 2021, 217(5): 1247 [2026-07-07]. https://www.ajronline.org/doi/10.2214/AJR.21.26005. DOI: 10.2214/ajr.21.26005.
[42]
Nursing group of Hubei Medical Association Interventional Medicine Branch, Interventional Physician Branch of Chinese Medical Association Interventional Surgery Group. Expert consensus on nursing management of intrathecal drug delivery systems for cancer pain[J]. J Nurs Sci, 2025, 40(8): 1-6. DOI: 10.3870/j.issn.1001-4152.2025.08.001.
[43]
American College of Radiology. ACR Manual on MR Safety[M/OL]. Reston, VA: American College of Radiology, 2026. https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Radiology-Safety/MR-Safety.
[44]
HOFMAN M B M, LAVINI C, VAN DER ZWAN A, et al. MRI in patients with a cerebral aneurysm clip; review of the literature and incident databases and recommendations for the Netherlands[J/OL]. Phys Med, 2024, 117: 103187 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/38016215/. DOI: 10.1016/j.ejmp.2023.103187.
[45]
Food and Drug Administration. Testing and Labeling Medical Devices for Safety in the Magnetic Resonance (MR) Environment: Guidance for Industry and Food and Drug Administration Staff[EB/OL]. (2021-05-20) [2026-07-26]. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/testing-and-labeling-medical-devices-safety-magnetic-resonance-mr-environment.
[46]
BHUSAL B, BHATTACHARYYA P, BAIG T, et al. Effect of inter-electrode RF coupling on heating patterns of wire-like conducting implants in MRI[J]. Magn Reson Med, 2022, 87(6): 2933-2946. DOI: 10.1002/mrm.29177.
[47]
LI X, ZENG X H, LIANG J L. Management standard of magnetic resonance imaging nursing practice[M]. Beijing: Science Press, 2025.
[48]
Imaging Technology Branch of Chinese Medical Association, Medical Technician Committee of Chinese Medical Doctor Association. Expert consensus on the safety of clinical application of MRI[J]. Chin J Radiol, 2023,57(9): 955-961. DOI: 10.3760/cma.j.cn112149-20230113-00036.
[49]
LUNDSTROM B N, LIN C, STARNES D K, et al. Safety and management of implanted epilepsy devices for imaging and surgery[J]. Mayo Clin Proc, 2022, 97(11): 2123-2138. DOI: 10.1016/j.mayocp.2022.06.012.
[50]
THIYAGARAJAH A, STRIK M, PLOUX S, et al. Contemporary management and programming of cardiac implantable electronic devices in patients undergoing magnetic resonance imaging[J/OL]. Heart Rhythm, 2026, 23(7): e1202-e1211 [2026-07-07]. https://www.heartrhythmjournal.com/article/S1547-5271(25)03148-0/abstract. DOI: 10.1016/j.hrthm.2025.12.014.
[51]
BARONI M, CARBONARO M, FELISI M M J, et al. Simplifying MRI workflow for patients with cardiac implantable electronic devices: Technologies for automatic MRI mode switching[J/OL]. Int J Cardiol, 2026, 444: 134006 [2026-07-07]. https://www.internationaljournalofcardiology.com/article/S0167-5273(25)01049-6/abstract. DOI: 10.1016/j.ijcard.2025.134006.
[52]
TANG M H, YAMAMOTO T. Progress in understanding radiofrequency heating and burn injuries for safer MR imaging[J]. Magn Reson Med Sci, 2023, 22(1): 7-25. DOI: 10.2463/mrms.rev.2021-0047.
[53]
YAO A P, GOREN T, LLOYD B, et al. Breast MRI in the prone position: impact on RF-induced heating of active implantable medical devices[J/OL]. Phys Med Biol, 2025, 70(17): 175003 [2026-07-07]. https://iopscience.iop.org/article/10.1088/1361-6560/adf58d. DOI: 10.1088/1361-6560/adf58d.
[54]
MULLEN L A. A how-to guide for expanding breast MRI access for patients with active implanted metallic devices[J/OL]. AJR Am J Roentgenol, 2026, 227(1): e2635020 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/41983877/. DOI: 10.2214/AJR.26.35020.
[55]
SANDERS J, PANDA A, HARPER L, et al. Breast MRI in patients with active implanted metallic devices: how we do it[J/OL]. AJR Am J Roentgenol, 2026, 227(1): e2634661 [2026-07-07]. https://pubmed.ncbi.nlm.nih.gov/41879732/. DOI: 10.2214/AJR.26.34661.
[56]
SAYED D, CHAKRAVARTHY K, AMIRDELFAN K, et al. A comprehensive practice guideline for magnetic resonance imaging compatibility in implanted neuromodulation devices[J]. Neuromodulation Technol Neural Interface, 2020, 23(7): 893-911. DOI: 10.1111/ner.13233.
[57]
RUPP R, BALK M, SIEVERT M, et al. Risk of magnetic resonance imaging-induced magnet dislocation for different types of cochlear implants: a single-center retrospective study[J/OL]. J Otolaryngol Head Neck Surg, 2023, 52(1): 28 [2026-07-07]. https://sage.cnpereading.com/doi/10.1186/s40463-023-00633-w. DOI: 10.1186/s40463-023-00633-w.
[58]
BARNSLEY H, ROBERTSON S, CRUICKSHANK S, et al. Radiographer training for screening of patients referred for Magnetic Resonance Imaging: a scoping review[J]. Radiography, 2024, 30(3): 843-855. DOI: 10.1016/j.radi.2024.03.009.
[59]
Nursing group of Radiology Branch of Chinese Medical Association, Nursing Group of Interventional Medicine Branch of Hubei Medical Association.. Expert consensus on safety training for clinical multi-post and whole-process personnel in MRI examination[J]. J Clin Radiol, 2026, 45(6): 948-955. DOI: 10.13437/j.cnki.jcr.2026.012.
[60]
HANSSON B, GLANS A, NORDIN L E, et al. Swedish national recommendations for MR safety 2026[J/OL]. Insights Imag, 2026, 17(1): 115 [2026-07-07]. https://link.springer.com/article/10.1186/s13244-026-02270-z. DOI: 10.1186/s13244-026-02270-z.

PREV Research progress on spatial correlation between multiparametric magnetic resonance imaging and pathological features of the tumor microenvironment
NEXT Effects of real-time fMRI neurofeedback targeting nucleus accumbens on brain-gut axis-related indicators in obese patients
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn